Sol-Gel Technologies (SLGL) Interest Expenses (2016 - 2025)
Sol-Gel Technologies' (SLGL) quarterly Interest Expenses came in at $58.5 million in Q4 2025, up 17.5% year-on-year from $49.8 million in Q4 2024, and up 17.5% on a QoQ basis from $49.8 million in Q4 2024.
Sol-Gel Technologies (SLGL) Interest Expenses (2016 - 2025) Analysis & Trends
Sol-Gel Technologies (SLGL) has 10 years of Interest Expenses data on file, last reported at $58.5 million in Q4 2025.
- On a quarterly basis, Interest Expenses rose 17.5% year-over-year to $58.5 million in Q4 2025; TTM through Dec 2025 was $58.5 million, a 17.5% increase from a year earlier, with the FY2025 full-year figure at $58.5 million, up 17.5% from the prior year.
- Interest Expenses for Q4 2025 stood at $58.5 million, up from $49.8 million in the prior quarter.
- Over the last five years, Interest Expenses for SLGL reached as high as $58.5 million in Q4 2025 and fell as low as $408000.0 in Q4 2021.
- Historically, Interest Expenses has averaged $40.3 million across 5 years, with a median of $47.9 million in 2023.
- Across the five-year window, Interest Expenses jumped 10854.41% in 2022 and increased 3.92% in 2024, its largest moves.
- Year by year, Interest Expenses stood at $408000.0 in 2021, then soared by 10854.41% to $44.7 million in 2022, then increased by 7.2% to $47.9 million in 2023, then grew by 3.92% to $49.8 million in 2024, then climbed by 17.5% to $58.5 million in 2025.
- Per Business Quant data, the three most recent Interest Expenses figures were $58.5 million in Q4 2025, $49.8 million in Q4 2024, and $47.9 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Sol-Gel Technologies | 234.04 Mn | 223.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 58.50 Mn |
| Dec 31, 2025 | 58.50 Mn |
| Dec 31, 2024 | 49.79 Mn |
| Dec 31, 2024 | 49.79 Mn |
| Dec 31, 2023 | 47.91 Mn |
| Dec 31, 2023 | 47.91 Mn |
| Dec 31, 2022 | 44.69 Mn |
| Dec 31, 2022 | 44.69 Mn |
| Dec 31, 2021 | 408,000.00 |
| Dec 31, 2021 | 408,000.00 |
| Dec 31, 2020 | 374,000.00 |
| Dec 31, 2020 | 374,000.00 |
| Dec 31, 2019 | 308,000.00 |
| Dec 31, 2019 | 308,000.00 |
| Dec 31, 2018 | 262,000.00 |
| Dec 31, 2018 | 262,000.00 |
| Dec 31, 2017 | 21.98 Mn |
| Dec 31, 2017 | 21.98 Mn |
| Dec 31, 2016 | 14.00 Mn |
| Dec 31, 2016 | 14.00 Mn |